Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

Mesoblast (MESO) EBITDA Margin: 2014-2023

Historic EBITDA Margin for Mesoblast (MESO) over the last 8 years, with Jun 2023 value amounting to -2,030.25%.

  • Mesoblast's EBITDA Margin rose 71975.00% to -2,030.25% in Q2 2023 from the same period last year, while for Jun 2023 it was -124.45%, marking a year-over-year increase of 9294.00%. This contributed to the annual value of -360.79% for FY2025, which is 74287.00% up from last year.
  • As of Q2 2023, Mesoblast's EBITDA Margin stood at -2,030.25%, which was down 445.90% from 586.95% recorded in Q1 2023.
  • In the past 5 years, Mesoblast's EBITDA Margin ranged from a high of 1,537.31% in Q1 2019 and a low of -4,929.45% during Q2 2021.
  • Over the past 3 years, Mesoblast's median EBITDA Margin value was 514.16% (recorded in 2022), while the average stood at -581.23%.
  • In the last 5 years, Mesoblast's EBITDA Margin plummeted by 510,679bps in 2020 and then surged by 524,810bps in 2021.
  • Mesoblast's EBITDA Margin (Quarterly) stood at 813.83% in 2019, then tumbled by 6,563bps to 748.19% in 2020, then crashed by 16,024bps to 587.96% in 2021, then slumped by 9,761bps to 490.35% in 2022, then spiked by 71,975bps to -2,030.25% in 2023.
  • Its last three reported values are -2,030.25% in Q2 2023, 586.95% for Q1 2023, and 490.35% during Q4 2022.